COVID-19 and Cancer
COVID-19 and the novel Sars-CoV-2 coronavirus has overshadowed much of 2020. Despite the promise of a vaccine on the horizon, the pandemic looks set to continue well into 2021 and the long-term effects of the disease may continue to cause concerns for healthcare systems.
Despite the damage and disruption that COVID-19 has, and is, causing around the world, the response of scientists to readjust their lab time and research priorities has been incredible. Clinical and translational oncologists have been working hard to consider the treatment and care of cancer patients under a new set of circumstances. In the first half of 2020, Future Oncology saw an increase in real-world data collection to work out the impact of COVID-19 on cancer patients, followed by a wealth of shorter articles considering how infection could be avoided in this patient group, and how treatment could be adjusted to reduce their susceptibility.
The evolution of the pandemic has been interesting for us as editors to observe, as the development of knowledge surrounding the disease has been so quick. It has been an excellent example of the turnover of scientific understanding and how answers will always lead to more questions.
We welcome you to read some of the best examples of our COVID-19-focussed content below.
